查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1422773

全球尿液檢測市場：按產品、按應用、按最終用戶、按地區、機會、預測，2017-2031年

Urinalysis Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 221 Pages | 商品交期: 3-5個工作天內

價格

全球尿液檢測市場預計將從 2023 年的 41.1 億美元成長到 2031 年的 64.4 億美元，在 2024-2031 年預測期內複合年增長率為 5.77%。

全球尿液檢測市場的顯著擴張是由於對家庭檢測的需求不斷增長、領先公司之間的合作、有利的技術進步、對預防性醫療保健的重視以及慢性病患病率的增加（特別是在老化中）推動的。人口）這是由於各種驅動力造成的。

在大眾對自我照顧和個人化健康管理的偏好推動下，居家尿液檢測設備的趨勢日益增長。 這些易於使用的工具可實現獨立的健康監測，更容易及早發現和解決潛在的健康問題。 領先產業參與者之間的合作關係匯集了專業知識、資源和技術，以刺激聯合創新。 這種合作關係加速了複雜尿液檢測解決方案的進步，擴大了我們在全球尿液檢測市場的影響力，並豐富了我們的產品供應。 人工智慧 (AI)、自動化和行動裝置的不斷進步正在改變尿液檢測的模式。 這些進步顯著提高了診斷過程的速度、準確性和便利性，從而增強了醫療保健提供者和個人的能力。

醫療保健趨勢越來越注重預防措施，鼓勵採用和開發尿液檢測工具以早期發現疾病。 積極的健康監測可以實現在疾病變得嚴重之前預防疾病的目標。 慢性病的快速增加以及世界人口的老化增加了頻繁尿液檢測的需求。 隨著與年齡相關的健康問題日益嚴重，對高效、準確的診斷設備的需求不斷增加，推動了全球尿液檢測市場的擴張。 這些相互關聯的因素正在塑造全球尿液檢測市場的動態成長，並滿足世界各地個人和社區不斷變化的醫療保健需求。

本報告考察了全球尿液檢測市場，並提供了市場概述，包括按產品、應用、最終用戶、地區和參與市場的公司概況劃分的趨勢。

目錄

第 1 章研究方法

第 2 章專案範圍與定義

第 3 章執行摘要

第 4 章 2017-2031 年全球尿液檢測市場前景

  • 市場規模與預測
  • 按產品
  • 依用途
  • 按最終用戶
  • 按地區
  • 各公司的市佔率 (%)，2023 年

第 5 章 2017-2031 年全球尿液檢測市場前景（按地區）

  • 北美
  • 歐洲
  • 南美洲
  • 亞太地區
  • 中東/非洲

第 6 章市場地圖，2023 年

第 7 章宏觀環境與產業結構

  • 需求與供給分析
  • 匯入/匯出分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市場動態

第 9 章監理架構與創新

第 10 章主要參會企業狀況

第 11 章價格分析

第 12 章案例研究

第 13 章主要公司展望

  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Cardinal Health, Inc.
  • Sysmex Corporation
  • Quidel Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • EKF Diagnostics
  • Becton, Dickinson and Company

第 14 章策略建議

第 15 章查詢及免責聲明

Product Code: MX10971

Global urinalysis market is projected to witness a CAGR of 5.77% during the forecast period 2024-2031, growing from USD 4.11 billion in 2023 to USD 6.44 billion in 2031.

The significant expansion of the global urinalysis market stems from various driving forces, such as growing demand for at-home testing, collaborative endeavors among major companies, favorable technological advancements, emphasis on preventive healthcare, and a rise in chronic ailments, especially among aging demographics.

There is a rising inclination toward at-home urinalysis devices, driven by the public's preference for self-care and tailored health management. These user-friendly tools enable independent health monitoring, facilitating early identification and handling of potential health issues. Partnerships between key industry players stimulate joint innovation, combining expertise, resources, and technological prowess. Such partnerships foster the advancement of sophisticated urinalysis solutions, broadening the global urinalysis market presence and enriching product offerings. Continuous advancements, notably in artificial intelligence (AI), automation, and portable devices, transform the landscape of urinalysis. These advancements notably enhance diagnostic processes' speed, precision, and convenience, thereby empowering both healthcare providers and individuals.

Healthcare trends increasingly focus on preventive measures, encouraging the adoption and development of urinalysis tools for early disease detection. Proactive health monitoring aligns with the aim of preventing illnesses before they escalate. The upsurge in chronic illnesses, combined with a globally aging population, drives the necessity for frequent urinalysis. With age-related health concerns rising, the demand intensifies for efficient and precise diagnostic instruments, propelling the expansion of the global urinalysis market. These interconnected elements collectively propel the dynamic growth of the global urinalysis market, molding it to cater to the evolving healthcare requisites of individuals and communities worldwide.

Increasing Focus on Preventive Healthcare

The growing emphasis on preventive healthcare significantly drives the expansion of the global urinalysis market. This focus stimulates the creation and application of urinalysis solutions for early disease detection. Urinalysis plays a crucial role in preventive healthcare by identifying potential health issues, enabling swift interventions, and halting disease progression. With healthcare models prioritizing prevention, there's an increased demand for precise urinalysis tools. This heightened demand solidifies their importance, establishing them as vital components in advancing worldwide healthcare strategies focused on proactive health management. Urinalysis contributes to the transition from reactive to proactive healthcare, fostering an ethos of early detection and intervention to enhance global health outcomes.

Technological Advancements

Technological advancements, particularly AI, are vital in driving the global urinalysis market. AI's incorporation brings about a revolution in urinalysis by significantly improving the accuracy, efficiency, and speed of analyzing and interpreting test results. By employing machine learning (ML) algorithms, AI rapidly recognizes patterns, irregularities, and potential health markers present in urine samples. This innovative technology streamlines diagnostic procedures, enabling faster and more precise identification of diseases or ailments. AI's capacity to learn and adapt enhances diagnostic capabilities, fostering a transition towards more tailored and efficient healthcare solutions. Its integration is pivotal in advancing urinalysis, amplifying its influence within global healthcare frameworks.

For example, in September 2022, the Israeli medical device startup Olive Diagnostics introduced a urinalysis equipment driven by artificial intelligence. The flagship product from Olive Diagnostics, Olive KG, is the first AI- and spectroscopy-based gadget in the world. It provides high-quality analysis of significant parameters in the patient's urine during each urination in a completely passive manner and doesn't require any further attachments.

Growing Popularity of Automated Urine Sediment Analyzer

The increasing adoption of automated urine sediment analyzers significantly boosts the global urinalysis market. These sophisticated systems streamline urine sample analysis by automating sediment examination, leading to heightened precision, speed, and effectiveness in identifying irregularities, thus facilitating faster and more accurate diagnoses. Furthermore, automation minimizes manual errors and labor-intensive processes, elevating reliability and throughput. This surge in usage mirrors the healthcare sector's amplified need for swift, precise, and consistent urinalysis, establishing automated urine sediment analyzers as crucial drivers behind the market's growth.

For instance, the world's first smart toilet clip-on device that would aid in the early diagnosis of health concerns was revealed by the wellness application Vivoo in January 2023. Launched at CES 2023 in Las Vegas, the smart toilet clip-on device can be added to current toilets and includes a urine strip in its seat. The risk of mess that can arise from handheld urine strips is eliminated when the strip automatically moves to align with the user's urine stream.

Growing Demand for At-home Devices

The increasing desire for at-home urinalysis devices is a significant driving force behind the global urinalysis market. These compact tools align with the growing trend of personalized healthcare, granting individuals the convenience of self-monitoring. Offering ease, precision, and instant insights, these devices empower users to oversee diverse health indicators within their home environment. Advancements in technology ensure accessible and prompt results, promoting proactive health maintenance. The rising inclination toward self-tracking and preventive healthcare further emphasizes the necessity for at-home urinalysis devices, establishing them as pivotal contributors to expanding the global urinalysis market.

For example, in January 2023, the medical device company Starling Medical announced the debut of StarStream, an at-home urine diagnostic patient monitoring platform. In contrast to traditional collection receptacles or dipsticks, StarStream examines the urine sample immediately.

Future Market Scenario (2024-2031F)

The future of the global urinalysis market looks promising, driven by several key factors. Technological advancements in AI and automation continually refine and improve urinalysis capabilities, enhancing diagnostic precision and efficiency. Growing demand for at-home testing devices and the emphasis on preventive healthcare further boost the growth of the global urinalysis market, meeting the demand for convenient proactive health monitoring solutions. Collaborations among industry leaders foster innovation, facilitating the development of sophisticated urinalysis tools. With an aging population and a rise in chronic conditions, the necessity for reliable and rapid diagnostic methods intensifies, strengthening the market's potential. These factors position the global urinalysis market for sustained expansion, addressing evolving healthcare needs and propelling advancements in diagnostic technologies worldwide for enhanced healthcare outcomes.

Key Players Landscape and Outlook

Large corporations in the global urinalysis market are progressively choosing to collaborate, merging their strengths. Through this union, these firms combine resources, research capabilities, and knowledge, nurturing innovation and broadening market reach. Such joint endeavors frequently result in the creation of state-of-the-art diagnostic technologies, innovative testing approaches, and improved product ranges. These partnerships also ease entry into new markets, stimulating growth and competitiveness. Ultimately, these collaborations cultivate a synergy that enables companies to better address evolving healthcare demands, delivering advanced urinalysis solutions on a global scale in a more comprehensive and efficient manner.

For example, in May 2023, Boehringer announced its partnership with Healthy.io to develop the first at-home, smartphone-based diagnostic tool, known as Minuteful Kidney Test, for screening individuals for chronic kidney disease (CKD). The traditional albumin-to-creatinine ratio (ACR) test, which finds protein in the urine and may indicate kidney disease at earlier stages, can be performed using the Minuteful Kidney test.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Urinalysis Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. Value
    • 4.1.2. Volume
  • 4.2. By Product
    • 4.2.1. Instruments
      • 4.2.1.1. Automated Urine Sediment Analyzer
      • 4.2.1.2. Biochemical Urine Analyzer
    • 4.2.2. Consumables
      • 4.2.2.1. Reagents
      • 4.2.2.2. Dipsticks
      • 4.2.2.3. Disposables
  • 4.3. By Application
    • 4.3.1. Urinary Tract Infections (UTI)
    • 4.3.2. Diabetes
    • 4.3.3. Pregnancy
    • 4.3.4. Kidney Disease
    • 4.3.5. Others
  • 4.4. By End-user
    • 4.4.1. Hospitals
    • 4.4.2. Home Healthcare
    • 4.4.3. Clinical Laboratories
    • 4.4.4. Others
  • 4.5. By Region
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. South America
    • 4.5.4. Asia-Pacific
    • 4.5.5. Middle East and Africa
  • 4.6. By Company Market Share (%), 2023

5. Global Urinalysis Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. Value
      • 5.1.1.2. Volume
    • 5.1.2. By Product
      • 5.1.2.1. Instruments
      • 5.1.2.1.1. Automated Urine Sediment Analyzer
      • 5.1.2.1.2. Biochemical Urine Analyzer
      • 5.1.2.2. Consumables
      • 5.1.2.2.1. Reagents
      • 5.1.2.2.2. Dipsticks
      • 5.1.2.2.3. Disposables
    • 5.1.3. By Application
      • 5.1.3.1.1. Urinary Tract Infections (UTI)
      • 5.1.3.1.2. Diabetes
      • 5.1.3.1.3. Pregnancy
      • 5.1.3.1.4. Kidney Disease
      • 5.1.3.1.5. Others
    • 5.1.4. By End-user
      • 5.1.4.1.1. Hospitals
      • 5.1.4.1.2. Home Healthcare
      • 5.1.4.1.3. Clinical Laboratories
      • 5.1.4.1.4. Others
    • 5.1.5. United States*
      • 5.1.5.1. Market Size & Forecast
      • 5.1.5.1.1. Value
      • 5.1.5.1.2. Volume
      • 5.1.5.2. By Product
      • 5.1.5.2.1. Instruments
      • 5.1.5.2.1.1. Automated Urine Sediment Analyzer
      • 5.1.5.2.1.2. Biochemical Urine Analyzer
      • 5.1.5.2.2. Consumables
      • 5.1.5.2.2.1. Reagents
      • 5.1.5.2.2.2. Dipsticks
      • 5.1.5.2.2.3. Disposables
      • 5.1.5.3. By Application
      • 5.1.5.3.1. Urinary Tract Infections (UTI)
      • 5.1.5.3.2. Diabetes
      • 5.1.5.3.3. Pregnancy
      • 5.1.5.3.4. Kidney Disease
      • 5.1.5.3.5. Others
      • 5.1.5.4. By End-user
      • 5.1.5.4.1. Hospitals
      • 5.1.5.4.2. Home Healthcare
      • 5.1.5.4.3. Clinical Laboratories
      • 5.1.5.4.4. Others
    • 5.1.6. Canada
    • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. South America
    • 5.3.1. Brazil
    • 5.3.2. Argentina
  • 5.4. Asia-Pacific
    • 5.4.1. India
    • 5.4.2. China
    • 5.4.3. Japan
    • 5.4.4. Australia
    • 5.4.5. Vietnam
    • 5.4.6. South Korea
    • 5.4.7. Indonesia
    • 5.4.8. Philippines
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Products
  • 6.2. By Application
  • 6.3. By End-user
  • 6.4. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts, Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. F. Hoffmann-La Roche Ltd.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Danaher Corporation
  • 13.3. Cardinal Health, Inc.
  • 13.4. Sysmex Corporation
  • 13.5. Quidel Corporation
  • 13.6. Siemens Healthineers AG
  • 13.7. Thermo Fisher Scientific Inc.
  • 13.8. Abbott Laboratories
  • 13.9. Bio-Rad Laboratories, Inc.
  • 13.10. EKF Diagnostics
  • 13.11. Becton, Dickinson and Company

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 2. Global Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 3. Global Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 5. Global Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 6. Global Urinalysis Market Share (%), By Region, 2017-2031F
  • Figure 7. North America Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 8. North America Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 9. North America Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 10. North America Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 11. North America Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 12. North America Urinalysis Market Share (%), By Country, 2017-2031F
  • Figure 13. United States Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 14. United States Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 15. United States Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 16. United States Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 17. United States Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 18. Canada Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 19. Canada Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 20. Canada Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 21. Canada Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 22. Canada Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 23. Mexico Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 24. Mexico Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 25. Mexico Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 26. Mexico Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 27. Mexico Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 28. Europe Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 29. Europe Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 30. Europe Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 31. Europe Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 32. Europe Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Urinalysis Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 35. Germany Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 36. Germany Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 37. Germany Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 38. Germany Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 39. France Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 40. France Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 41. France Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 42. France Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 43. France Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 44. Italy Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 45. Italy Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 46. Italy Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 47. Italy Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 48. Italy Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 49. United Kingdom Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 50. United Kingdom Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 51. United Kingdom Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 52. United Kingdom Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 53. United Kingdom Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 54. Russia Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 55. Russia Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 56. Russia Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 57. Russia Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 58. Russia Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 59. Netherlands Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 60. Netherlands Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 61. Netherlands Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 62. Netherlands Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 63. Netherlands Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 64. Spain Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 65. Spain Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 66. Spain Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 67. Spain Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 68. Spain Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 69. Turkey Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 70. Turkey Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 71. Turkey Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 72. Turkey Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 73. Turkey Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 74. Poland Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 75. Poland Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 76. Poland Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 77. Poland Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 78. Poland Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 79. South America Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 80. South America Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 81. South America Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 82. South America Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 83. South America Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 84. South America Urinalysis Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 86. Brazil Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 87. Brazil Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 88. Brazil Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 89. Brazil Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 90. Argentina Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 91. Argentina Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 92. Argentina Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 93. Argentina Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 94. Argentina Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 95. Asia-Pacific Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 96. Asia-Pacific Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 97. Asia-Pacific Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 98. Asia-Pacific Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 99. Asia-Pacific Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 100. Asia-Pacific Urinalysis Market Share (%), By Country, 2017-2031F
  • Figure 101. India Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 102. India Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 103. India Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 104. India Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 105. India Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 106. China Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 107. China Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 108. China Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 109. China Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 110. China Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 111. Japan Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 112. Japan Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 113. Japan Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 114. Japan Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 115. Japan Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 116. Australia Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 117. Australia Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 118. Australia Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 119. Australia Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 120. Australia Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 121. Vietnam Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 122. Vietnam Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 123. Vietnam Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 124. Vietnam Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 125. Vietnam Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 126. South Korea Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 127. South Korea Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 128. South Korea Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 129. South Korea Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 130. South Korea Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 131. Indonesia Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 132. Indonesia Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 133. Indonesia Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 134. Indonesia Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 135. Indonesia Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 136. Philippines Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 137. Philippines Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 138. Philippines Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 139. Philippines Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 140. Philippines Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 141. Middle East & Africa Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 142. Middle East & Africa Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 143. Middle East & Africa Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 144. Middle East & Africa Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 145. Middle East & Africa Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 146. Middle East & Africa Urinalysis Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 148. Saudi Arabia Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 149. Saudi Arabia Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 150. Saudi Arabia Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 151. Saudi Arabia Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 152. UAE Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 153. UAE Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 154. UAE Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 155. UAE Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 156. UAE Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 157. South Africa Urinalysis Market, By Value, in USD Billion, 2017-2031F
  • Figure 158. South Africa Urinalysis Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 159. South Africa Urinalysis Market Share (%), By Product, 2017-2031F
  • Figure 160. South Africa Urinalysis Market Share (%), By Application, 2017-2031F
  • Figure 161. South Africa Urinalysis Market Share (%), By End-user, 2017-2031F
  • Figure 162. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023